285 related articles for article (PubMed ID: 37687122)
1. Natural Products: A Dependable Source of Therapeutic Alternatives for Inflammatory Bowel Disease through Regulation of Tight Junctions.
Peng J; Li H; Olaolu OA; Ibrahim S; Ibrahim S; Wang S
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687122
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease.
Guo BJ; Bian ZX; Qiu HC; Wang YT; Wang Y
Ann N Y Acad Sci; 2017 Aug; 1401(1):37-48. PubMed ID: 28891095
[TBL] [Abstract][Full Text] [Related]
3. Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease.
Li B; Wang Y; Jiang X; Du H; Shi Y; Xiu M; Liu Y; He J
Biomed Pharmacother; 2023 Aug; 164():114950. PubMed ID: 37263167
[TBL] [Abstract][Full Text] [Related]
4. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments.
Zhou Y; Wang D; Yan W
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839389
[TBL] [Abstract][Full Text] [Related]
5. Coumarin Derivatives in Inflammatory Bowel Disease.
Di Stasi LC
Molecules; 2021 Jan; 26(2):. PubMed ID: 33467396
[TBL] [Abstract][Full Text] [Related]
6. The Potential of Natural Oils to Improve Inflammatory Bowel Disease.
Zhou Y; Wang D; Duan H; Zhou S; Guo J; Yan W
Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299569
[TBL] [Abstract][Full Text] [Related]
7. Natural Product-Based Nanomedicine in Treatment of Inflammatory Bowel Disease.
Khare T; Palakurthi SS; Shah BM; Palakurthi S; Khare S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486445
[No Abstract] [Full Text] [Related]
8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
9. Discovery of small-molecule candidates against inflammatory bowel disease.
Bai R; Jie X; Yao C; Xie Y
Eur J Med Chem; 2020 Jan; 185():111805. PubMed ID: 31703817
[TBL] [Abstract][Full Text] [Related]
10. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
Schlegel N; Boerner K; Waschke J
Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
[TBL] [Abstract][Full Text] [Related]
11. Potential of Plant-sourced Phenols for Inflammatory Bowel Disease.
Xiao HT; Wen B; Shen XC; Bian ZX
Curr Med Chem; 2018; 25(38):5191-5217. PubMed ID: 28990509
[TBL] [Abstract][Full Text] [Related]
12. Epithelial tight junctions in intestinal inflammation.
Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
[TBL] [Abstract][Full Text] [Related]
13.
Hung YK; Ho ST; Kuo CY; Chen MJ
Int J Med Sci; 2021; 18(8):1778-1785. PubMed ID: 33746595
[No Abstract] [Full Text] [Related]
14. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
Yoo JH; Donowitz M
World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
[TBL] [Abstract][Full Text] [Related]
15. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
17. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
18. The potential roles of natural plant polysaccharides in inflammatory bowel disease: A review.
Yang W; Zhao P; Li X; Guo L; Gao W
Carbohydr Polym; 2022 Feb; 277():118821. PubMed ID: 34893238
[TBL] [Abstract][Full Text] [Related]
19. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
20. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
